Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $511.7 million.

  • Bio-Techne's Total Liabilities fell 1355.26% to $511.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $511.7 million, marking a year-over-year decrease of 1355.26%. This contributed to the annual value of $639.1 million for FY2025, which is 63.67% up from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Total Liabilities is $511.7 million, which was down 1355.26% from $560.3 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Total Liabilities peaked at $767.2 million during Q4 2023, and registered a low of $511.7 million during Q4 2025.
  • In the last 5 years, Bio-Techne's Total Liabilities had a median value of $612.5 million in 2021 and averaged $627.2 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 2416.86% in 2021, then soared by 4305.45% in 2023.
  • Bio-Techne's Total Liabilities (Quarter) stood at $601.9 million in 2021, then fell by 10.89% to $536.3 million in 2022, then soared by 43.05% to $767.2 million in 2023, then fell by 22.84% to $591.9 million in 2024, then decreased by 13.55% to $511.7 million in 2025.
  • Its Total Liabilities was $511.7 million in Q4 2025, compared to $560.3 million in Q3 2025 and $639.1 million in Q2 2025.